Literature DB >> 31996845

PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis.

Kwanha Yu1, Chia-Ching John Lin1, Asante Hatcher2, Brittney Lozzi1, Kathleen Kong1, Emmet Huang-Hobbs1, Yi-Ting Cheng1, Vivek B Beechar1, Wenyi Zhu1, Yiqun Zhang3, Fengju Chen3, Gordon B Mills4, Carrie A Mohila5, Chad J Creighton3,6, Jeffrey L Noebels2,7,8, Kenneth L Scott7, Benjamin Deneen9,10,11.   

Abstract

Glioblastoma is a universally lethal form of brain cancer that exhibits an array of pathophysiological phenotypes, many of which are mediated by interactions with the neuronal microenvironment1,2. Recent studies have shown that increases in neuronal activity have an important role in the proliferation and progression of glioblastoma3,4. Whether there is reciprocal crosstalk between glioblastoma and neurons remains poorly defined, as the mechanisms that underlie how these tumours remodel the neuronal milieu towards increased activity are unknown. Here, using a native mouse model of glioblastoma, we develop a high-throughput in vivo screening platform and discover several driver variants of PIK3CA. We show that tumours driven by these variants have divergent molecular properties that manifest in selective initiation of brain hyperexcitability and remodelling of the synaptic constituency. Furthermore, secreted members of the glypican (GPC) family are selectively expressed in these tumours, and GPC3 drives gliomagenesis and hyperexcitability. Together, our studies illustrate the importance of functionally interrogating diverse tumour phenotypes driven by individual, yet related, variants and reveal how glioblastoma alters the neuronal microenvironment.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31996845      PMCID: PMC7577741          DOI: 10.1038/s41586-020-1952-2

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

1.  Loss of p53 protein strikes a nerve to aid tumour growth.

Authors:  Marco Napoli; Elsa R Flores
Journal:  Nature       Date:  2020-02       Impact factor: 49.962

2.  Synaptic Communication in Brain Cancer.

Authors:  Michelle Monje
Journal:  Cancer Res       Date:  2020-05-07       Impact factor: 12.701

3.  Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model.

Authors:  Asante Hatcher; Kwanha Yu; Jochen Meyer; Isamu Aiba; Benjamin Deneen; Jeffrey L Noebels
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 4.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

5.  Roadmap for the Emerging Field of Cancer Neuroscience.

Authors:  Michelle Monje; Jeremy C Borniger; Nisha J D'Silva; Benjamin Deneen; Peter B Dirks; Faranak Fattahi; Paul S Frenette; Livia Garzia; David H Gutmann; Douglas Hanahan; Shawn L Hervey-Jumper; Hubert Hondermarck; Jonathan B Hurov; Adam Kepecs; Sarah M Knox; Alison C Lloyd; Claire Magnon; Jami L Saloman; Rosalind A Segal; Erica K Sloan; Xin Sun; Michael D Taylor; Kevin J Tracey; Lloyd C Trotman; David A Tuveson; Timothy C Wang; Ruth A White; Frank Winkler
Journal:  Cell       Date:  2020-04-16       Impact factor: 41.582

6.  Sox9 directs divergent epigenomic states in brain tumor subtypes.

Authors:  Debosmita Sardar; Hsiao-Chi Chen; Amanda Reyes; Srinidhi Varadharajan; Antrix Jain; Carrie Mohila; Rachel Curry; Brittney Lozzi; Kavitha Rajendran; Alexis Cervantes; Kwanha Yu; Ali Jalali; Ganesh Rao; Stephen C Mack; Benjamin Deneen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-15       Impact factor: 12.779

7.  PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response.

Authors:  Jie Li; Megan M Kaneda; Jun Ma; Ming Li; Ryan M Shepard; Kunal Patel; Tomoyuki Koga; Aaron Sarver; Frank Furnari; Beibei Xu; Sanjay Dhawan; Jianfang Ning; Hua Zhu; Anhua Wu; Gan You; Tao Jiang; Andrew S Venteicher; Jeremy N Rich; Christopher K Glass; Judith A Varner; Clark C Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

8.  ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.

Authors:  Amir Arabzade; Yanhua Zhao; Srinidhi Varadharajan; Hsiao-Chi Chen; Selin Jessa; Bryan Rivas; Austin J Stuckert; Minerva Solis; Alisha Kardian; Dana Tlais; Brian J Golbourn; Ann-Catherine J Stanton; Yuen San Chan; Calla Olson; Kristen L Karlin; Kathleen Kong; Robert Kupp; Baoli Hu; Sarah G Injac; Madeline Ngo; Peter R Wang; Luz A De León; Felix Sahm; Daisuke Kawauchi; Stefan M Pfister; Charles Y Lin; H Courtney Hodges; Irtisha Singh; Thomas F Westbrook; Murali M Chintagumpala; Susan M Blaney; Donald W Parsons; Kristian W Pajtler; Sameer Agnihotri; Richard J Gilbertson; Joanna Yi; Nada Jabado; Claudia L Kleinman; Kelsey C Bertrand; Benjamin Deneen; Stephen C Mack
Journal:  Cancer Discov       Date:  2021-03-19       Impact factor: 39.397

Review 9.  Mini-review: Trophic interactions between cancer cells and primary afferent neurons.

Authors:  Patrick J Hunt; Fabiola N Andújar; Deborah A Silverman; Moran Amit
Journal:  Neurosci Lett       Date:  2021-01-19       Impact factor: 3.046

10.  Identification of diverse tumor endothelial cell populations in malignant glioma.

Authors:  Jeff C Carlson; Manuel Cantu Gutierrez; Brittney Lozzi; Emmet Huang-Hobbs; Williamson D Turner; Burak Tepe; Yiqun Zhang; Alexander M Herman; Ganesh Rao; Chad J Creighton; Joshua D Wythe; Benjamin Deneen
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.